On Jun. 2, 2020, Pfizer announced the establishment of the Pfizer Breakthrough Growth Initiative, through which Pfizer will invest up to $500 million in biotechnology companies to help provide funding and access to Pfizerﾒs scientific expertise to ensure continuity of the biotechnology companiesﾒ most promising clinical development programs.